Ann: CMO Appointment and Clinical Trials Update, page-140

THIS

This is what the major shareholders, directors etc have been buying shares for. Over the last 12 months directors have been buying on market, in the cap raise and 2 major shareholders also put in over $1m, clearly unconcerned with daily fluctuations. Almost 12 months ago Hugh Alsop was appointed specifically for the task of negotiating a deal and during the 12 months, we have had the data from phase 2a.

"Dimerix Limited Executive Chairman James Williams said, "We are excited to have someone of Hugh's calibre and experience joining the board of Dimerix. Hugh's knowledge of the industry, experience in negotiating licensing and partnership deals combined with his extensive network of contacts compliment the current board and management team. We look forward to his contribution to all aspects of the business.""

http://dimerix.com/wp-content/uploads/ASXHughDirector.pdf